DexCom, Inc. (DXCM)
NASDAQ · Healthcare
DexCom, Inc. Shareholder Equity 2020–2025
DexCom, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- DexCom, Inc. shareholder equity as of December 31, 2025: 2.75B, a 30.60% increase year-over-year.
- DexCom, Inc. shareholder equity for 2025 were 2.75B, a 30.60% increase from 2024.
- DexCom, Inc. shareholder equity for 2024 were 2.10B, a 1.64% increase from 2023.
- DexCom, Inc. shareholder equity for 2023 were 2.07B, a 2.96% decrease from 2022.
- DexCom, Inc. shareholder equity for 2022 were 2.13B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| DexCom, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $2,746 |
| 2024 | $2,103 |
| 2023 | $2,069 |
| 2022 | $2,132 |
| 2021 | $2,042 |
| 2020 | $1,827 |
DexCom, Inc. Shareholder Equity — FAQ
DexCom, Inc. (DXCM) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DXCM's shareholder equity history?
The chart and table above show DexCom, Inc.'s shareholder equity by year and by quarter, including the growth rate.